Integrated Diagnostics Holdings PLC is one of the largest customer medical care organizations in the Middle East and Africa, with Egypt, Jordan, Sudan, and Nigeria. The Company works in three geographic regions: Egypt, Sudan, and Jordan. The Company offers more than 1,000 indicative types of assistance from actual tests to tests for hepatitis, and particular deoxyribonucleic acid (DNA) tests to patients and works roughly 310 branches. The company offers a scope of administrations, like Immunology, Radiology, Haematology, Endocrinology, Molecular Biology, Cytogenetics, Hematopathology, and Microbiology.
The Company's famous brands are Al Borg and Al Mokhtabar for Egypt, just as Biolab in Jordan, and Ultralab and Al Mokhtabar Sudan in Sudan. The Company also has the Medical Genetics Center brand in Egypt. Its Al Mokhtabar clinical testing and demonstrative focus offer types of assistance, including radiological tests, a middle for hypersensitivity, a unit for dietary exhortation, pre-occupations tests, clinical assessment in various fields, and test bundles.
The Company plans to be a leading medical care supplier locally, and to the area it serves, turning into each specialist and patient's best option for quality, precise demonstrative testing, and financially savvy administrations. Past the counter-recurrent nature of the medical care industry, the exceptionally divided and underpenetrated heart of IDH's Middle East and African business sectors set out development freedom for the Group.
Many underlying development drivers set up that support a strong future for indicative clinical administrations in these arising districts, including enormous, quickly developing populaces; high illness trouble with the decrease in living standard, and the uplifted well-being cognizance of a rising working class. The mechanics of the medical services markets in which IDH works are extraordinarily unique concerning those in most western nations.
IDH serves the private medical care market, in which patients have generously more opportunity to settle on medical care choices than their partners in more standardized business sectors. IDH is all around situated to profit by these significant industry elements with solid brands, an enormous set-up of top-notch clinical indicative administrations, and a resource-light plan of action that empowers a broad geographic reach. With over 30 years of industry experience and vital extension, IDH has assembled a solid market position across items and topographies, with a versatile stage set for substantial additional development.
Integrated Diagnostics Holdings PLC 12 Castle Street JE2 3RT Jersey